01
03




-
CentryMed
Featured Technologies -
Targeted ActivationOur proprietary Pro-BiTE? platform activates
Tcells selectively within the tumor
microenvironment (TME), -
Safer Treatmentsignificantly reducing systemic toxicity and
unlocking safer T-cell therapies for solid
tumors.



